PeimanHemattiMD

Oncology • Milwaukee, WI

Hematologic Oncology

Professor of Medicine, Director, Cell Therapy Laboratory

Join to view full profile

Dr. Hematti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hematti's full profile

Already have an account?

Office
9200 W Wisconsin Ave
Milwaukee, WI 53226
Phone+1 414-805-0505

Fax+1 414-955-0231

Summary

Dr. Peiman Hematti is Director of Cell Therapy Lab at Froedtert Hospital and Medical College of Wisconsin. He received his medical degree from Tehran University of Medical Sciences School of Medicine and has been in practice 20 years. He has close to 200 publications, more than a dozen book chapters and several patents.

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
Cleveland Clinic FoundationResidency, Internal Medicine/Pediatrics, 1995 - 1999
Tehran University of Medical Sciences School of MedicineClass of 1990

Certifications & Licensure

WI State Medical License 2004 - 2025
OH State Medical License 1999 - 2004
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Pediatrics Pediatrics

Clinical Trials

A Study to Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002) Start of enrollment: 2022 Jun 16
Terminated
Phase 3
Roles: Contact

Publications & Presentations

PubMed

Biobehavioral mechanisms underlying symptoms in cancer patients with chronic graft-versus-host disease.
Jenna L Hansen, Meredith E Rumble, Christopher L Coe, Mark B Juckett, Mikayla A Foster
Brain, Behavior, and Immunity. 2025-01-01
Correction: Psychological and physical function in allogeneic hematopoietic cell transplant survivors with chronic graft-versus-host disease.
Jenna L Hansen, Mark B Juckett, Mikayla A Foster, Meredith E Rumble, Keayra E Morris
Journal of Cancer Survivorship. 2024-12-01
Outcomes with chimeric antigen receptor T-cell therapy in Rheumatological disorders: A systematic review.
Fizza Zulfiqar, Moazzam Shahzad, Muhammad Kashif Amin, Abhinav Vyas, Zouina Sarfraz
Transplant Immunology. 2024-12-01

Journal Articles

Effect of Human Corneal Mesenchymal Stromal Cell-Derived Exosomes on Corneal Epithelial Wound Healing
Peiman Hematti, Medi Eslani, Ravand Samaeekia, Investigative Ophthalmology and Visual Science
Bioengineering Solutions for Manufacturing Challenges in CAR T Cells
Peiman Hematti, Christian M Capitini, Biotechnology Journal

Abstracts/Posters

Versican Proteolytic Fragments (Matrikines) Regulate the Intratumoral Dendritic Cell Milieu In Vivo: Implications for in Situ Tumor Vaccination
Peiman Hematti, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Versican (VCAN) Proteolysis Predicts Survival in Multiple Myeloma (MM) after High Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT/AHCT)
Peiman Hematti, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Children and Young Adults with Acute Lymphoblastic Leukemia (ALL): Real World E...
Peiman Hematti, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Children and Young Adults with Acute Lymphoblastic Leukemia (ALL): Real World E...
Peiman Hematti, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Impact of Antibiotics on Gut Microbiota Diversity and the Results of a Prospective Dietary Assessment in Patients with Multiple Myeloma Undergoing Autologous Hematopoi...
Peiman Hematti, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Post-Marketing Use Outcomes of an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, Axicabtagene Ciloleucel (Axi-Cel), for the Treatment of Large B Cell Lympho...
Peiman Hematti, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Join now to see all

Lectures

A Phase II Study of Decitabine Followed By Allogeneic Hematopoietic Stem Cell Transplantation in High-Risk Patients with Myeloid Malignancies
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

UW Health 1st in US to Treat Heart Disease Patient with Cell TherapyNovember 1st, 2021
Exosome-Educated Macrophages Show Potential to Treat Ligament InjuriesNovember 4th, 2020
Therapeutic Plasma Exchange: A Potential Management Strategy for Critically Ill COVID-19 PatientsJuly 15th, 2020
Join now to see all

Grant Support

Exosome educated monocytes for acute radiation syndrome MPI with Christian CapitiniNIH/NHLBI2021–2026
Embryonic Stem Cell Derived HSC Transplantation In Rhesus Macaque ModelNational Heart, Lung, And Blood Institute2007–2011
Rhesus Macaque Hematopoietic Stem Cell ExpansionNational Center For Research Resources2005–2006